Zobrazeno 51 - 60
of 1 205
pro vyhledávání: '"63"'
Publikováno v:
Journal of Clinical Oncology. 31:e14599-e14599
e14599 Background: Pelvic recurrence of rectal cancer is a persisting therapeutic challenge in spite of wide spread use of adjuvant/neoadjuvant chemo radiation and wide resection isolated pelvic perfusion (IPP) may facilitate pelvic resection in sele
Autor:
Amit Rauthan, S.P. Somashekhar
Publikováno v:
Journal of Clinical Oncology. 31:e11510-e11510
e11510 Background: Sentinel node biopsy has emerged as the standard of care in clinically node negative breast cancer (cT1,T2 N0). In cases where sentinel node is negative, ALND can be avoided. In nearly 30-50% cases, the sentinel lymph nodes is the
Autor:
Kazuaki Nakashima, Hikaru Fujioka, Hiroaki Tohyama, Masahiro Ito, Yasuhiro Nagata, Shigeto Maeda, Yukiko Tokai, Yukio Kamohara
Publikováno v:
Journal of Clinical Oncology. 31:e11605-e11605
e11605 Background: Hormone therapy is recommended for treating patients with luminal A type early breast cancer by the International Conference in St. Gallen, 2011. However, precisely which neoadjuvant therapeutic strategies are optimal for such pati
Autor:
Dana Zakalik, Ishmael Jaiyesimi, Lindsay Dohany, Mohammad Muhsin Chisti, Seerin Viviane Shatavi
Publikováno v:
Journal of Clinical Oncology. 31:1541-1541
1541 Background: Worldwide ethnic variations in the distribution of BRCA1 and BRCA2 mutations of breast cancer patients have been recently recognized. This has led to investigations of the epidemiology, genetics and clinical characteristics of BRCA p
Autor:
Shinichiro Yoshida, Naoya Taira, Naokuni Uike, Kenji Ishitsuka, Yukiyoshi Moriuchi, Masao Tomonaga, Kazuhito Yamamoto, Ryuzo Ueda, Kimiharu Uozumi, Atae Utsunomiya, Toshihiro Miyamoto, Tatsuro Jo, Hitoshi Suzushima, Kisato Nosaka, Yoshio Saburi, Takashi Ishida, Kensei Tobinai, Hiroshi Fujiwara, Shigeki Takemoto, Kazunori Imada
Publikováno v:
Web of Science
8506 Background: Mogamulizumab (Moga), a defucosylated humanized anti-CCR4 antibody, was approved for the treatment of relapsed/refractory ATL in Japan in 2012. This multicenter, randomized, phase II trial was conducted to examine the efficacy of the
Publikováno v:
Journal of Clinical Oncology. 31:435-435
435 Background: Renal cell carcinoma (RCC) venous extension is a challenging condition. Its prognostic significance is not well established. We investigated possible prognostic correlations between venous extension in RCC, with its various levels, an
Autor:
Prasad Cooray, Andrew Dean
Publikováno v:
Journal of Clinical Oncology. 30:e14644-e14644
e14644 Background: Resection offers the only probability of cure for pancreatic adenocarcinoma but only a minority have resectable disease at diagnosis. Effective neo-adjuvant therapy for LAPC could down-size the tumor rendering it resectable. Neo-ad
Autor:
Sanjiv S. Agarwala, Lisa Sengeløv, Sunil Sharma, TX Quyen Nguyen, Frederick Millard, Peter J. Van Veldhuizen, Shaker R. Dakhil, Ari David Baron, Jeffrey Yachnin, Jean-Pascal Machiels, Gedske Daugaard, James L. Wade, Patricia M. M. B. Soetekouw, Sylvie Rottey, William A. Conkright, Pierre Maison-Blanche, Mustapha Chadjaa
Publikováno v:
Journal of Clinical Oncology. 30:e15115-e15115
257 Background: Cabazitaxel (Cbz) improves overall survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel failure, compared with mitoxantrone (HR 0.70; 95% CI 0.59–0.83; P < 0.0001). Following Cbz ap
Autor:
Louis B. Harrison, Rania A. Shourbaji, Kenneth S. Hu, Waleed F. Mourad, Bruce Culliney, Zujun Li
Publikováno v:
Journal of Clinical Oncology. 30:5559-5559
5559 Background: OP of HNSCC is commonly treated with comprehensive mucosal RT including nasopharynx, OPX, hypopharynx and larynx and bilateral neck. We are reporting the long term outcomes of a conservative mucosal sparing technique consisting of ta
Autor:
Lei Han, Kathleen I. Pritchard, Judy-Anne W. Chapman, Timothy J. Whelan, Wendy R. Parulekar, Lois E. Shepherd, Paul E. Goss, Abdullah Altwairgi
Publikováno v:
Journal of Clinical Oncology. 30:500-500
500 Notice of Retraction: "Impact of concurrent (CON) and sequential (SEQ) radiotherapy (RT) with adjuvant aromatase inhibitors (AI) in early-stage breast cancer (EBC): NCIC CTG MA.27." Abstract 500, published in the 2012 Annual Meeting Proceedings P